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Summary
 
Background
 
Cold thyroid nodules are common, in particular in
iodine-deﬁcient areas, but only a minority of them are malignant
requiring surgery. Thyroid peroxidase (TPO) immunostaining of
ﬁne-needle aspiration cytology (FNAC) material has proven helpful
in diagnosing cells from malignant lesions, but the procedure has its
limitations in a routine setting.
 
Purpose
 
To improve diagnosis and reduce surgery rate, the FNAC
procedure was replaced by needle core biopsy (NCB), which was
routinely stained for TPO by the monoclonal antibody mAb 47.
 
Materials and methods
 
During a 5-year period 427 consecutive
patients with a cold thyroid nodule were evaluated by ultrasound-
guided NCB, which had been routinely stained for TPO in an
automated immunostainer. Sensitivity and speciﬁcity and predictive
values of the TPO immunostaining were estimated, based on the
ﬁnal diagnosis obtained from surgical resection.
 
Results
 
The majority of nodules with benign NCB diagnosis were
not surgically removed, and thus a subgroup of 140 operated nodules
formed the basis for the calculations. Sensitivity and speciﬁcity for
benign and malignant lesions were 100% if the oxyphilic variant of
adenomas and minimally invasive follicular carcinomas were
excluded. By inclusion of these, the values fell to 89% and 97%,
respectively. The predictive value of a positive test was 96% and the
predictive value of a negative test was 97%.
 
Conclusion
 
TPO immunostaining was found to be a valuable
adjunct to morphology in the diagnosis of cold thyroid nodules of
the nonoxyphilic type.
(Received 3 July 2007; returned for revision 5 August 2007; ﬁnally 
revised 24 September 2007; accepted 10 October 2007)
 
Introduction
 
Cold nodules of the thyroid gland present themselves as hypofunction-
ing areas by 
 
99,m
 
technetium scintigraphy. Until recently, Denmark
was a country of iodine deﬁciency
 
1
 
 and therefore these nodules are
common. The risk of malignancy varies from approximately 1% in
the USA up to 24% in other countries depending on iodine intake
and reference pattern.
 
1–6
 
 Most benign cold nodules in areas of iodine
deﬁciency appear to be solitary nodules in a colloid goitre, and less
frequently follicular adenomas or localized thyroiditis. Malignant
nodules are mainly carcinomas, and, less frequently, lymphomas or
metastases. In iodine-deﬁcient areas papillary carcinoma is by far the
most common of the malignant tumours (83·2%), followed by
follicular/Hürtle-cell carcinoma (9·7%), medullary carcinoma (1·7%)
and undifferentiated carcinoma (1%).
 
7
 
 However, the incidence of
diagnosed thyroid carcinoma is increasing, with an estimated rise of
3% per year in both Denmark
 
8
 
 and the USA.
 
2,7
 
Fine-needle aspiration cytology (FNAC) has been the standard
method for differentiating between benign and malignant nodules,
but as cystic degeneration, bleeding, necrosis and calciﬁcations are
common features of both benign and malignant nodules, routine
FNAC is highly person dependent and may carry a low sensitivity
and speciﬁcity, resulting in a high surgery rate for benign nodules.
 
9–14
 
Other diagnostic methods have therefore been introduced, including
ultrasound-guided FNAC
 
15–17
 
 and ultrasound-guided needle core
biopsy (NCB).
 
18–24
 
 The enzyme thyroid peroxidase (TPO) appears
to be changed early in malignant transformation, and it has been
discussed whether this enzyme might be a marker of benign 
 
vs.
 
malignant thyroid lesions.
 
25
 
 The monoclonal antibody 47 (mAb 47)
has a high afﬁnity for TPO of normal or benign thyrocytes but a very
weak or absent afﬁnity for the TPO of malignant epithelial cells, in
particular those from nonfollicular malignancies.
 
26–30
 
We have previously shown, in a prospective immunocytochemical
study, that mAb 47 was a valuable tool for enhancing the ability to
discriminate benign from malignant lesions in optimally obtained
and handled FNACs. Sensitivity and speciﬁcity were 100% and 99%,
respectively.
 
31
 
 In a routine setting, however, cytological sampling and
immunostaining was not optimal with respect to suitable material,
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time and manpower, and we decided to replace ultrasound-guided
FNAC with ultrasound-guided NCB as our standard sampling
procedure.
 
Materials and methods
 
A prospective study was conducted during the 5-year period from
1999 to 2004 with the purpose of evaluating the diagnostic sensitivity
and speciﬁcity of ultrasound-guided NCBs routinely stained for
morphological markers [haematoxylin/eosin (H&E), van Gieson/
Alcian blue (VG/A)] and for TPO in an automated immunostainer.
Three senior pathologists who specialize in diagnosing thyroid
lesions participated. Ongoing mutual consultations secured
diagnostic uniformity. The biopsies were given one of the following
diagnoses: benign, not otherwise speciﬁed (NOS), colloid goitre,
atypia, adenoma, suspicious, papillary carcinoma, undifferentiated
carcinoma, and paraganglioma. The diagnosis ‘atypia’ was used if the
tissue differed from normal but did not show any signs of malignancy,
and ‘suspicious’ was used if a malignant diagnosis was assumed but was
not obvious. The diagnosis ‘adenoma’ was short for the term ‘follicular
neoplasia, unknown whether benign or malignant’. This was used
particularly if the biopsy material contained part of a ﬁbrous capsule.
The NCB diagnosis based on routine H&E and VG/A morphology
was compared with its TPO expression. The ﬁnal diagnosis for the
excised nodule was reached according to World Health Organization
(WHO) guidelines from sections stained with H&E and VG/A, and,
if necessary, by sections stained immunohistochemically for TPO,
CK19, calcitonin, CD56 and thyroglobulin.
 
23
 
 All of these were com-
pared with the TPO expression of the corresponding NCB.
TPO immunostaining was considered positive (benign) if 80% or
more of the follicular epithelial cells were stained, either homo-
geneously in all cells or in a patchy pattern, and negative (malignant)
if less than 80% of the cells were stained.
 
25,27
 
 The visual impression
scoring was convincing to the degree where interobserver variations
regarding TPO staining pattern (positive 
 
vs.
 
 negative) were not found.
All other participating doctors at the different diagnostic and thera-
peutic levels were also specialized in thyroid disease.
A total of 427 patients were included in the study: 334 women
(aged 9–86 years, median 46 years) and 93 men (aged 15–85 years,
median 50 years). Each patient had a palpable solitary thyroid
nodule, which was cold by 
 
99,m
 
technetium scintigraphy, or a dominant
cold nodule in a goitrous gland, for which they underwent, with local
anaesthesia, ultrasound-guided NCB and TPO immunostaining.
With regard to the sampling procedure, a preceding pilot study of
25 cases including both FNAC and NCB had already convinced
the participating specialist at the ultrasound unit (F.J.) that the tar-
geting was the same for the two procedures. Only sampling type
and hence eligibility of the biopsy material differed. The study was
consecutive and included all patients who were admitted to the
hospital with a cold thyroid nodule. Only patients on thrombolytic
treatment were excluded. Prior to sampling the patients were
informed of the risk of slight bruising and pain at the biopsy site for
a few days.
All patients were clinically and biochemically euthyroid. Three
patients with insufﬁcient biopsy material were excluded from the
study, leaving a total of 424 patients.
 
Surgery
 
Unilateral or bilateral thyroidectomy was performed in 140 patients
(33%), while the majority of patients, 284 (67%), were not operated
upon as a consequence of full diagnostic procedure including
NCB diagnosis, patient’s request or, in the case of undifferentiated
carcinomas, inoperability. These patients were all enrolled in a regular
follow-up programme including visits 7 days after sampling (histo-
logical diagnosis and possible side-effects of the procedure), followed
up by regular visits every 6 months with clinical palpation, standard
thyroid blood tests, and re-biopsy in case of any changes or irregu-
larities. The last check-ups were registered after 2–7 years.
For the 140 surgically removed nodules, diagnostic sensitivity
(%  TPO-negative/malignant nodules) and diagnostic speciﬁcity
(% positive/benign nodules) were calculated. We also calculated the
predictive value of a positive test for malignancy (% TPO-negative
malignant/TPO-negative biopsies) and the predictive value of a
negative test (% TPO-positive benign/TPO-positive biopsies).
The study was part of an ongoing quality assurance programme.
During the study period (and even today) NCB sampling was (and is)
a routine procedure. All patients had been informed of and agreed
to the procedure. The previous FNAC study with automatic inclusion
of TPO staining and the pilot study comparing FNAC and NCB
sampling had both been approved by the local ethical committee.
Possible changes in surgery rates for cold thyroid nodules diag-
nosed by FNAC and NCB, respectively, were evaluated by comparing
lists of operated patients with pathology lists of all FNAC and/or frozen
section biopsies during the previous 5-year period (1994–99).
 
Results
 
All follicular epithelial cells from benign, nonoxyphilic lesions
showed an intense TPO-positive cytoplasmic staining (Fig. 1), while
more than 80% of tumour cells of papillary, medullary, undifferen-
tiated and widely invasive follicular carcinomas were TPO negative
(Fig. 2). Table 1 shows the correlation between H&E morphology
Fig. 1 TPO stained typical NCB from a colloid goitre. All the follicular cells 
are intensely stained (arrows). 
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and TPO immunoreactivity on all 424 biopsies. One lesion turned
out to be a paraganglioma of nonthyroid origin and hence TPO
negative. This benign tumour was not subsequently removed. All the
malignant, the one suspicious and two of the seven atypical lesions
were TPO negative. Five biopsies with ‘atypia’ and eight with
‘adenoma’ contained oncocytic cells, which tended to give a spotted,
irregular TPO staining (Fig. 3). Apart from slight bruising, which
disappeared within a few days, no serious complications in the
biopsy procedure (bleeding/haematoma, nerve lesion or pain lasting
more than 1–2 days) were registered.
 
No surgery
 
Biopsies from patients who did not undergo subsequent surgery
were diagnosed as either ‘benign’ or ‘goitre’, and were TPO positive
(Table 1). Included in this category also was a TPO-negative para-
ganglioma of nonthyroid origin and four cases of inoperable
undifferentiated carcinoma, all of which were TPO negative. At follow-
up none of the patients had undergone additional biopsy or surgery.
 
Surgery
 
Table 2 shows the TPO staining pattern of the 140 surgically removed
nodules. Diagnostic concordance between TPO-negative, NCB-
based preliminary and postoperative ﬁnal diagnosis was 100% for
carcinomas of papillary (
 
n
 
 = 17), widely invasive follicular (
 
n
 
 = 1),
medullary (
 
n
 
 = 1) and undifferentiated (
 
n
 
 = 3) subtypes (Table 2).
Minimally invasive follicular carcinomas and adenomas were not
reliably diagnosed from the NCB, neither by morphology nor
by TPO immunostaining (Tables 2–4). On NCB, three had been
Fig. 2 NCB from a papillary carcinoma, stained 
for H&E (left) and TPO (right). All tumour cells 
(bottom) are negative and all surrounding benign 
follicular cells are positive (arrows).
Table 1. Needle core-based diagnosis and corresponding thyroid peroxidase 
(TPO) expression of all (operated and nonoperated) cold nodules
H&E diagnosis
TPO expression
Positive Negative Total
Benign NOS 221 221
Goitre 139 139
Atypia 5 2 7
Adenoma 28 3 31
Suspicious 1 1
Papillary carcinoma 17 17
Undifferentiated carcinoma 7 7
Paraganglioma 1 1
Total 393 31 424
H&E, haematoxylin–eosin; NOS, not otherwise speciﬁed.
Table 2. Needle-core thyroid peroxidase (TPO) expression and ﬁnal 
histological diagnosis for the 140 patients who underwent thyroidectomy
H&E diagnosis
TPO expression
Positive Negative Total
Benign NOS 15 15
Goitre 67 67
Adenoma 30 1 31
Papillary carcinoma 17 17
Minimally invasive follicular carcinoma 3 2 5
Widely invasive follicular carcinoma 1 1
Medullary carcinoma 1 1
Undifferentiated carcinoma 3 3
Total 115 25 140
NOS, not otherwise speciﬁed. 
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diagnosed as oxyphilic adenomas being TPO positive (Table 4), and
the remaining two had been diagnosed as TPO-negative papillary
carcinomas (Table 3). The majority of adenomas were TPO positive
(30/31), but for the minimally invasive follicular carcinomas three
were TPO positive and two TPO negative (Table 2).
In two cases of nodular goitre the ﬁnal surgical specimen con-
tained microscopic foci (2 mm and 3 mm, respectively) of papillary
carcinoma (one in each patient). These were accidental ﬁndings,
and the biopsy had not been taken from the area where they were
identiﬁed.
The diagnostic sensitivity was 89% and the diagnostic speciﬁcity
was 97%. The predictive values of a positive and a negative test were
96% and 97%, respectively.
Surgery lists and pathology reports from the previous 5  years
(1994–99) revealed that 164 out of 303 cold nodules that had been
diagnosed by FNAC alone (54%) had been removed surgically. In
this study (1999–2004) only 140 out of the 427 cold nodules
that had been diagnosed by NCB alone (33%) had been removed.
Nodules removed during the pilot study and nodules diagnosed by
frozen section sampling were not included.
 
Discussion
 
This hospital-based, multidisciplinary prospective study running
over a period of 5 years was carried out with the purpose of ﬁnding
Table 4. Needle-core biopsy (NCB) diagnosis correlated to ﬁnal histology 
diagnosis for thyroid peroxidase (TPO) positive excised cold nodules
NCB diagnosis
Final histology diagnosis
Benign Goitre Adenoma
Minimally invasive 
follicular carcinoma Total
Benign NOS 10 37 9 56
Goitre 5 22 2 29
Atypia 1 2 3
Adenoma 7 17 3 27
Total 15 67 30 3 115
NOS, not otherwise speciﬁed.
Fig. 3 NCB from an oxyphilic adenoma, stained 
for Van Gieson Alcian blue (left) and TPO (right). 
Most oxyphilic cells fail to stain for TPO. The 
surrounding normal follicular cells are positive 
(arrows).
Table 3. Needle-core biopsy (NCB) diagnosis correlated to ﬁnal histology diagnosis for thyroid peroxidase (TPO) negative excised cold nodules
NCB diagnosis
Final histology diagnosis
Adenoma
Papillary 
carcinoma
Minimally invasive 
follicular carcinoma
Widely invasive 
follicular carcinoma
Medullary 
carcinoma
Undifferentiated 
carcinoma Total
Atypia 2 2
Adenoma 1 2 3
Suspicious 1 1
Papillary carcinoma 14 1 1 1 17
Undifferentiated carcinoma 22
Total 1 17 2 1 1 3 25 
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a more precise diagnostic procedure than FNAC in differentiating
between benign and malignant cold thyroid nodules in an area with
long-standing borderline low-incidence iodine intake.
 
1,3,5
 
The aim was to reduce the number of unnecessary surgical thyroid
resections, and TPO immunostaining, which had previously proven
to be an excellent marker of benign 
 
vs.
 
 malignant lesions in optimally
handled FNACs,
 
31
 
 was used systematically as an adjunct to morpho-
logy. The optimal approach that would have provided the added
value of NCB would have been to prolong the pilot study, performing
both NCB and FNAC in each case, and then offer surgery based on
FNAC criteria. However, the pilot study had, in our hands, shown
a more exact and reliable diagnosis from the NCB than from the
FNAC procedure, and clinicians and patients decided in a substantial
number of cases to refrain from surgery if a clear-cut benign diag-
nosis had been made in addition to the other results of the diagnostic
work-up. As a result, only about one-third (33%) of the nodules
(
 
n
 
 = 140) were removed, apparently reducing surgery rate in com-
parison with the previous 5 years, where 54% had been removed, by
21%. However, this difference must be interpreted with caution, as
both this and our previous FNAC study, which took place during
1993–96, may have instigated variations in sampling frequency. As
previously noted by us
 
31
 
 and others,
 
28,30
 
 the encapsulated lesions,
follicular adenomas and, in particular, minimally invasive follicular
carcinomas, which in this study were of the oxyphilic type, were
unreliable in their TPO staining and their sole responsibility for the
value reductions (Tables 2–4). The majority of follicular adenomas
were TPO positive (
 
n
 
 = 30), as expected for benign lesions, and two out
of the ﬁve minimally invasive follicular carcinomas were expectedly
TPO negative. However, one adenoma with oxyphilic metaplasia was
judged to be TPO negative, and three minimally invasive follicular
carcinomas, also showing oxyphilic metaplasia, were judged to be
TPO positive. This weakened the efﬁcacy of TPO immunostaining
for these particular lesions and it was therefore not possible to
distinguish them preoperatively by their TPO expression alone.
Currently, the only valid criteria for differentiating between adenoma
and minimally invasive follicular carcinoma are focal capsular
penetration and/or vessel invasion of the latter.
 
32
 
Although the diagnostic sensitivity and speciﬁcity as well as
predictive values for TPO positivity and negativity could only be
established for one-third of the patients, the shift from FNAC to NCB
allowed a greater number of pathologists to diagnose the lesions in
a shorter time. It also provided both patients and surgeons with a
more clear-cut benign diagnosis than before, and the frequency
of thyroid surgery for cold nodules consequently appeared to be
reduced by 21% when comparing surgery rate of the previous 5 years
based on FNAC with the surgery rate of this study. For the same
reason, speciﬁcity, sensitivity and predictive values of the TPO
immunostaining was based on the 140 patients, who had a deﬁnite
histological diagnosis after resection of their cold nodules.
Previous studies comparing FNAC and NCB have been conﬂicting
regarding usefulness of the latter.
 
18–24,33
 
 Some have focused on a
higher risk and the psychological impact of the NCB procedure,
 
20
 
although bleeding was the only and rare complication observed,
 
18,19,24
 
and others have found similar sensitivity and speciﬁcity values
for the two procedures when optimally handled.
 
20,22
 
 However, a
majority of reports have ended up recommending FNAC and NCB
to be used complementarily,
 
19,21–24
 
 so that surgery on hyperplastic
nodules
 
24
 
 and the number of false-positive and false-negative
ﬁndings
 
22
 
 can be reduced to a minimum.
We are not aware of any previous prospective and systematic NCB
studies with inclusion of TPO immunostaining as a routine proce-
dure. However, other studies on surgical material have conﬁrmed
our observations. Although TPO was signiﬁcantly reduced or negative
in all nonfollicular neoplasms, it was not of sufﬁcient discriminatory
value in the diagnosis of follicular adenoma 
 
vs.
 
 carcinoma,
 
30,34
 
 in
particular of the oxyphilic type.
 
34
 
 These results have been conﬁrmed
by observations on TPO mRNA analyses on 20 thyroid carcinomas,
 
28
 
and it has further been demonstrated that the reduced TPO
antigenicity is due to a quantitative rather than a qualitative loss.
 
29
 
The reason to use a cut-off point for TPO positivity of 80% was
based on observations on FNAC made by three other studies.
 
25–27
 
The lesion was most likely to be benign if 80–100% of the epithelial
cells were stained, and malignant if less than 80%, and in most cases,
less than 40%, of the epithelial cells were stained. Sensitivity and
speciﬁcity of this method were found to be 100% and 86·7%,
respectively.
 
25–27
 
 In accordance with their ﬁndings, we did identify all
nonfollicular carcinomas by their lack of TPO immunostaining. This
was also true for the follicular variant of the papillary carcinoma.
This tumour type can be difﬁcult to diagnose on H&E morphology
alone, but TPO immunostaining has in recent years been supple-
mented with immunostaining for the cytokeratin marker, CK19, a
well-known reliable positive marker of papillary carcinomas.
 
35
 
An obvious advantage of the NCB rather than the FNAC pro-
cedure is the ability to diagnose encapsuled lesions by the former,
as part of the surrounding capsule will show up as a ﬁbrous band
on the biopsy.
 
36
 
 This has minimized the numbers of possible
adenomas and therefore reduced the number of consequential
surgical resections. A disadvantage of the NCB is its limited value in
obtaining sufﬁcient material from cystic or haemorrhagic lesions
and the obvious psychological impact on the patient of the sampling
procedure. Microscopic foci of papillary carcinoma were seen in two
resections, although the benign TPO-positive biopsies had given
morphological evidence of a benign goitre. This was not surprising.
Papillary microcarcinomas, deﬁned as tumours of 1 cm or less, are
common incidental ﬁndings in a nodular goitre or in the thyroid
glands of Graves’ disease.
 
37,38
 
 In this study they were 2 and 3 mm,
respectively, and unlikely to have shown any clinical symptoms.
In conclusion, this study has shown that replacing FNAC with NCB
sampling from the cold thyroid nodule has provided surgeons with
a more speciﬁc diagnosis, and possibly a resultant reduced surgery
rate. In addition, TPO immunostaining of an NCB is a valuable
additional tool in the differentiation between benign and malignant
scintigraphically cold thyroid nodules of the nonoxyphilic type.
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